You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
Register for free to read this article
As a service to the community, this article is available for free. Existing users log in.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Sjögren’s Research to Make Your Mouth Water
Sjögren’s syndrome is an autoimmune disorder where the body’s own immune cells attack and destroy the exocrine glands that produce such things as tears and saliva. Some patients may have only minor irritation, whereas others may have more serious systemic effects. Sjögren’s syndrome is most common in women over 40, and treatment only attempts to alleviate the symptoms—there is no cure. Now, Rusakiewicz et al. implicate natural killer (NK) cells in the pathogenesis of Sjögren’s syndrome.
The authors found that a genetic polymorphism is NKp30, an NK cell–activating receptor, associated with susceptibility to Sjögren’s syndrome in human patients compared with healthy controls. NK cells in these patients expressed high levels of NKp30 and secreted more proinflammatory cytokines. What’s more, these NK cells accumulated in inflammatory foci in minor salivary glands, and salivary epithelial cells expressed B7H6, a ligand that activates NKp30. These data strongly suggest that NK cells may contribute to Sjögren’s syndrome pathogenesis, and put forth NKp30 as a therapeutic target, providing a potential oasis for Sjögren’s patients.
- Copyright © 2013, American Association for the Advancement of Science